Amparo Alba-Redondo

Amparo Alba-Redondo

Auto-generated profile, based on publicly available information

Amparo Alba-Redondo

Laboratory Department, Hospital Univeritari i Politècnic la Fe. Av Fernando Abril Martorell 106; 46026 València, Spain

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
PLPedro López-Muñoz
Pedro López-Muñoz
BBBelén Beltran
Belén Beltran
ESEsteban Sáez-González
Esteban Sáez-González
AAAmparo Alba
Amparo Alba
PNPilar Nos
Pilar Nos
MIMarisa Iborra
Marisa Iborra
Vitamin D has recently been discovered to be a potential immune modulator. Low serum vitamin D levels have been associated with risk of relapse and exacerbation of clinical outcomes in Crohn’s disease (CD) and ulcerative colitis (UC). A retrospective, longitudinal study was conducted to determine the association between vitamin D levels and inflammatory markers and clinical disease activity in inflammatory bowel disease (IBD). In addition, circulating 25(OH)D3 progression was evaluated according to vitamin D supplementation. Participants were separated into three groups according to their vitamin D level: severe deficiency (SD), moderate deficiency (MD) and sufficiency (S). Serum 25(OH)D3 was inversely correlated with faecal calprotectin (FC) for CD and UC but was only correlated with C-reactive protein (CRP) for UC patients. In the multivariate analysis of FC, CRP and fibrinogen (FBG), we predicted the presence of a patient in the SD group with 80% accuracy. A deficiency of 25(OH)D3 was associated with increased hospitalisations, flare-ups, the use of steroids and escalating treatment. Supplemental doses of vitamin D were likely to be insufficient to reach adequate serum levels of 25(OH)D3. Vitamin D intervention studies are warranted to determine whether giving higher doses of vitamin D in IBD might reduce intestinal inflammation or disease activity.

24 December 2023 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
JTJordi Tortosa-Carreres
Jordi Tortosa-Carreres
CLCarmen Lloret-Sos
Carmen Lloret-Sos
JSJose Miguel Sahuquillo-Arce
Jose Miguel Sahuquillo-Arce
PSPedro Suárez-Urquiza
Pedro Suárez-Urquiza
JPJosep Prat-Fornells
Josep Prat-Fornells
JHJose Luis Lopez- Hontangas
Jose Luis Lopez- Hontangas